Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Equity

v3.10.0.1
Condensed Consolidated Statement of Equity - 9 months ended Sep. 30, 2018 - USD ($)
$ in Thousands
Total
Series B Preferred Stock
Total Shareholders’ Equity
Total Shareholders’ Equity
Series B Preferred Stock
Preferred Stock
Series A Preferred Stock
Preferred Stock
Series B Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Noncontrolling Interests
Beginning balance, shares at Dec. 31, 2017         562 1,875,848 8,744,189     635,018
Beginning balance at Dec. 31, 2017 $ 70,596   $ 63,508   $ 453 $ 40,915 $ 87 $ 226,978 $ (204,925) $ 7,088
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Accretion of Series B Preferred Stock discount 509 $ 65   $ 65   $ 65        
Conversion of Series B Preferred Stock to Common Stock, shares           (100) 62      
Conversion of Series B Preferred Stock to Common Stock           $ (2)   2    
Conversion of operating partnership units into common stock, shares             339,468     (339,468)
Conversion of operating partnership units to Common Stock     1,298       $ 3 1,295   $ (1,298)
Issuance of common stock under Share Incentive Plan, shares             168,217      
Issuance of Common Stock under Share Incentive Plan 894   894       $ 2 892    
Issuance of Common Stock for acquisition of JANAF, shares             150,000      
Issuance of Common Stock for acquisition of JANAF 1,130   1,130       $ 2 1,128    
Adjustment for noncontrolling interest in operating partnership     2,706         2,706   (2,706)
Dividends and distributions (9,621)   (9,621)           (9,621)  
Net Loss (4,022)   (3,952)           (3,952) $ (70)
Ending balance, shares at Sep. 30, 2018         562 1,875,748 9,401,936     295,550
Ending balance at Sep. 30, 2018 $ 59,042   $ 56,028   $ 453 $ 40,978 $ 94 $ 233,001 $ (218,498) $ 3,014